Headache Treatments
Michael A. Rogawski, M.D., Ph.D.
  • Migraine and Migraine Treatments
  • Search
  • Headache Types
  • Acute Migraine Treatment (status migrainosus), Triptans, NSAIDs
  • Emergency Department Treatment
  • Preventative Migraine Treatments
  • Tension Type Headache
  • Children and Adolescents
  • Medication Overuse Headache
  • IV Infusion Protocols
  • Posttraumatic Headache
  • Migraine Mimics
  • High and Low Pressure Headache
  • Devices
  • Lawrence Robbins: Advanced Headache Therapy
  • Hemiplegic Migraine
  • Cluster Headache Treatment
  • CGRP Antibodies and Gepants
  • Headache Tracking
  • Sleep
  • Triggers/Caffeine
  • Depression Screening PHQ-2 and PHQ-9
  • Publications
  • Menstruation, Menopause, Pregnancy and Breastfeeding
  • Hormonal Therapies: Menopause and OCPs
  • Butterbur
  • Prodrome and Aura
  • Tinnitus
  • Behavioral Therapy
  • Exercise
  • Magnesium, Nutritional Supplements and Alternative
  • Hypertension Guidlines
  • MIDAS (Migraine Disability Assessment) and ASC-12
  • Botox
  • Nerve Blocks
  • Cannabinoids
  • Deprescribing/ Withdrawing Medications
  • Epilepsy/Seizure Drugs in Development
  • Occipital Epilepsy
  • Restaurants, Attractions & Hikes

AED Efficacy from Pivotal Trials

Slater J, Chung S, Huynh L, Duh MS, Gorin B, McMislater-efficacy-aeds-partial-onset-seizures-meta-analysis-epilepsyres2018.pdfcken C, Ziemann A, Isojarvi J. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials. Epilepsy Res. 2018 Jul;143:120-129.
Picture
Picture

Epilepsy/Seizure Drugs in Development

​Staccato® alprazolam

Engage Therapeutics​

Vigadrone (Vigabatrin)

500 mg/packet. ANDA of Aucta Pharmaceuticals LLC marketed by Upsher-Smith Laboratories.

​Libervant (DBSF)

Aquestive

AAV SCN1A Dravet

Encoded Therapeutics